| Date Filed | Type | Description |
| 01/05/2023 |
4
| McVicar William K. (Director) has filed a Form 4 on Salarius Pharmaceuticals, Inc.|
Txns:
| Granted 1,440 shares
@ $0 |
|
| 06/07/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/21/2022 |
4
| McVicar William K. (Director) has filed a Form 4 on Salarius Pharmaceuticals, Inc.|
Txns:
| Granted 30,000 options to buy
@ $0.48, valued at
$14.4k
|
|
| 12/04/2020 |
4
| McVicar William K. (Director) has filed a Form 4 on Salarius Pharmaceuticals, Inc.|
Txns:
| Granted 30,000 options to buy
@ $0.74, valued at
$22.2k
|
|
| 03/25/2020 |
4
| McVicar William K. (Director) has filed a Form 4 on Salarius Pharmaceuticals, Inc.|
Txns:
| Granted 6,000 options to buy
@ $0.61, valued at
$3.7k
|
|
| 02/13/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/12/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/12/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/18/2018 |
4
| McVicar William K. (President and CEO) has filed a Form 4 on Flex Pharma, Inc.|
Txns:
| Granted 359,696 options to buy
@ $1.35, valued at
$485.6k
|
|
| 01/19/2018 |
4
| McVicar William K. (President and CEO) has filed a Form 4 on Flex Pharma, Inc.|
Txns:
| Granted 250,000 options to buy
@ $3.98, valued at
$995k
|
|
| 07/27/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/30/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 04/12/2017 |
3
| Form 3 - Initial statement of beneficial ownership of securities |
| 03/24/2016 |
4
| McVicar William K. (See Remarks) has filed a Form 4 on INOTEK PHARMACEUTICALS CORP|
Txns:
| Granted 135,000 options to buy
@ $7.56, valued at
$1M
|
|